Health
By Benprince Ezeh
OSAGIE Ehanire, minister of health has said that the Delta variant of COVID-19 virus is already dominant in Nigeria and the citizens must take required protective measures and increase testing to determine our situation.
Speaking at the Presidential Steering Committee, PSC, on COVID-19 briefing in Abuja on Monday, the minister said that the dreaded 3rd wave of COVID-19 might appear to be levelling out because there had been no catastrophic increases in infections and fatalities.
“It is not wise to assume that the threat is gone, especially as cases are fluctuating and have to be identified by genomic sequencing.
”Evidence so far, however, is that the Delta strain is already the dominant one in Nigeria. We must keep our protective measures in place and increase testing to determine our situation.
“There are reports of new coronavirus mutations circulating in other countries, a development we shall monitor with all the tools available to us, to ensure we respond appropriately,” the minister said.
According to him, people should remain on alert at points of entry, including land and sea borders, to confront importation of COVID-19.
“Several cases have indeed been identified by rapid diagnostic tests and taken care of accordingly,” he stressed.
However, the minister said that the government had secured nearly 40 million doses of Johnson & Johnson, J&J, vaccines to be arriving at a rate that National Primary Health Care Development Agency, NPHCDA, would set, to align with their utilization strategy.
“All states have received doses of AstraZeneca, Moderna and J&J vaccines for the ongoing second phase of the vaccination exercise in all states, while the federal government has done due diligence to ensure vaccine quality and safety.
“Available data shows that there have been no serious adverse effects so far, following vaccinations so that confidence in vaccines we are using is upheld, and we have a good mix and quantity of vaccines and do not envisage shortages, despite news reports that vaccines allocated to Africa will be reduced by 25 percent soon.
”We believe the reduction may be linked to increased demand in high income countries, many of whom have commenced third booster doses of COVID-19 and or reduced vaccine eligibility age in their countries to 12 years or even less. This tells us that the vaccine is effective and that we should also accept it.
“We shall also surely receive donor doses, so that we do not expect to be impacted by the expected shortfall,” Ehanire said.
First published – Sept. 15, 2021 @ 14:09 GMT | C.E
Tags: Abuja AstraZeneca Covid-19 Johnson & Johnson Osagie Ehanire
